IL1B and early-onset autosomal dominant Alzheimer disease: Administration of a reversible small caspase-1 specific inhibitor VX-765 in Alzheimer’s disease model of mice showed improvement of mice clinical behaviors, resulted in decrease in hippocampal and cortical IL-1β levels and prevented amyloid beta deposit (Flores et al., 2018).